Senzime

Senzime is a medical technology company based in Uppsala, Sweden, founded in 1999. It is publicly listed on the Stockholm Stock Exchange under the symbol SEZI. The company focuses on developing and manufacturing monitoring and diagnostic systems for healthcare, with a strong emphasis on automating the measurement of critical substances like glucose and lactate in blood and tissues. Senzime's products are designed to support healthcare institutions and physicians by providing reliable and automated biochemical monitoring solutions. These systems play a vital role in patient monitoring across various clinical settings, enabling healthcare professionals to make informed decisions. With a growing global market presence, Senzime serves a diverse customer base within the healthcare sector.

• Employees54
• Founded1999
• Annual Revenue$5322000
• Total Funding$8250000